ACADIA Pharmaceuticals (ACAD) Insider Trading & Ownership → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free ACAD Stock Alerts $18.20 +0.41 (+2.30%) (As of 03/27/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ACADIA Pharmaceuticals (NASDAQ:ACAD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage27.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$5.31 MNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$7.89 M Get ACAD Insider Trade Alerts Want to know when executives and insiders are buying or selling ACADIA Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ACAD Insider Buying and Selling by Quarter Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionStart Your Risk-Free Trial Here ACADIA Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/27/2024Brendan TeehanCOOSell5,140$17.90$92,006.00 3/27/2024Mark C SchneyerCFOSell5,434$17.90$97,268.60 3/27/2024Stephen DavisCEOSell17,714$17.90$317,080.60 2/26/2024Brendan TeehanCOOSell624$24.67$15,394.08 2/26/2024James KiharaInsiderSell474$24.67$11,693.58 2/26/2024Mark C SchneyerCFOSell772$24.67$19,045.24 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/26/2024Stephen DavisCEOSell5,577$24.67$137,584.59 1/8/2024Austin D KimEVPSell590$29.96$17,676.40 1/8/2024Brendan TeehanCOOSell731$29.96$21,900.76 1/8/2024Stephen DavisCEOSell3,732$29.96$111,810.72 12/15/2023James KiharaInsiderSell2,000$28.30$56,600.00 11/20/2023Brendan TeehanCOOSell4,960$22.64$112,294.40 11/20/2023James KiharaInsiderSell1,985$22.64$44,940.40 11/20/2023Mark C SchneyerCFOSell5,108$22.64$115,645.12 10/6/2023Austin D KimEVPSell16,369$21.96$359,463.24 10/6/2023Stephen DavisCEOSell51,563$21.96$1,132,323.48 9/15/2023James KiharaInsiderSell2,000$25.88$51,760.00 8/21/2023Mark C SchneyerCFOSell10,000$29.00$290,000.00 7/14/2023Stephen DavisCEOSell100,000$30.04$3,004,000.00 7/11/2023Stephen DavisCEOSell16,498$25.00$412,450.00 6/15/2023James KiharaInsiderSell2,000$24.15$48,300.00 6/12/2023Laura BregeDirectorSell4,500$24.87$111,915.00 6/8/2023Mark C SchneyerCFOSell974$25.02$24,369.48 5/23/2023Bros. Advisors Lp BakerDirectorBuy209,053$25.41$5,312,036.73 5/17/2023Brendan TeehanCOOSell14,869$22.50$334,552.50 5/17/2023James KiharaInsiderSell5,947$22.50$133,807.50 5/17/2023Mark C SchneyerCFOSell15,310$22.50$344,475.00 5/1/2023Austin D KimEVPSell917$21.18$19,422.06 5/1/2023Brendan TeehanCOOSell548$21.18$11,606.64 5/1/2023Stephen DavisCEOSell7,806$21.18$165,331.08 4/10/2023James KiharaInsiderSell523$18.14$9,487.22 4/6/2023Austin D KimEVPSell1,456$18.16$26,440.96 4/6/2023Brendan TeehanCOOSell1,751$18.16$31,798.16 4/6/2023James KiharaInsiderSell701$18.16$12,730.16 4/6/2023Mark C SchneyerCFOSell1,916$18.16$34,794.56 4/6/2023Stephen DavisCEOSell8,582$18.16$155,849.12 (Data available from 1/1/2013 forward) ACAD Insider Trading Activity - Frequently Asked Questions Who is on ACADIA Pharmaceuticals's Insider Roster? The list of insiders at ACADIA Pharmaceuticals includes Austin D Kim, Brendan Teehan, Bros. Advisors Lp Baker, Elena Ridloff, James Kihara, Laura Brege, Mark C Schneyer, Srdjan R Stankovic, and Stephen Davis. Learn more on insiders at ACAD. What percentage of ACADIA Pharmaceuticals stock is owned by insiders? 27.50% of ACADIA Pharmaceuticals stock is owned by insiders. Learn more on ACAD's insider holdings. Which ACADIA Pharmaceuticals insiders have been buying company stock? The following insider purchased ACAD shares in the last 24 months: Bros. Advisors Lp Baker ($5,312,036.73). How much insider buying is happening at ACADIA Pharmaceuticals? Insiders have purchased a total of 209,053 ACAD shares in the last 24 months for a total of $5,312,036.73 bought. Which ACADIA Pharmaceuticals insiders have been selling company stock? The following insiders have sold ACAD shares in the last 24 months: Austin D Kim ($464,425.49), Brendan Teehan ($647,358.64), James Kihara ($403,618.11), Laura Brege ($340,040.00), Mark C Schneyer ($948,129.29), Srdjan R Stankovic ($100,884.05), and Stephen Davis ($5,719,639.07). How much insider selling is happening at ACADIA Pharmaceuticals? Insiders have sold a total of 360,087 ACADIA Pharmaceuticals shares in the last 24 months for a total of $8,624,094.65 sold. More Insider Trading Tools from MarketBeat Related Companies: Crinetics Pharmaceuticals Insider Trades Gemini Therapeutics Insider Trades MoonLake Immunotherapeutics Insider Trades Arvinas Insider Trades IDEAYA Biosciences Insider Trades Xenon Pharmaceuticals Insider Trades Bausch Health Companies Insider Trades Arrowhead Pharmaceuticals Insider Trades Amicus Therapeutics Insider Trades Merus Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders Are Buying That Analysts LoveInsider Selling of Amazon Spikes in Q1, but it's Not Time to Sell3 Small Dividend Paying Banks Insiders are Buying3 Stocks Insiders are Buying at New HighsInsider selling at JPM: A Closer Look Amidst Historic CEO Sale This page (NASDAQ:ACAD) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.